What is Evidium?
Evidium, Inc. is a pioneering healthcare AI company dedicated to converting complex medical knowledge into actionable computational intelligence. Their sophisticated platform unifies fragmented clinical data and models patient journeys with a strong grounding in evidence-based guidelines. This enables the delivery of crucial foresight concerning disease progression, care pathways, and associated costs. By enhancing large language models with transparent reasoning capabilities, Evidium empowers healthcare leaders to make more informed, rapid, and confident decisions, thereby bridging the gap between clinical practice and financial coverage.
How much funding has Evidium raised?
Evidium has raised a total of $22M across 1 funding round:
Series A
$22M
Series A (2025): $22M with participation from Health2047, Interwoven Ventures, and Mindset Ventures
Key Investors in Evidium
Health2047
Health2047, a venture studio powered by the American Medical Association, focuses on founding and scaling healthcare companies. They invest in innovations that enhance diagnostics, utilize technology, and improve care delivery, aiming for impactful solutions and healthy returns.
Interwoven Ventures
Interwoven Ventures is an early-stage venture capital firm specializing in robotics, AI, and healthcare technology. They support founders with strategic guidance and operational expertise to scale groundbreaking solutions that transform traditional industries.
Mindset Ventures
Mindset Ventures is a venture capital firm that invests in early-stage B2B startups, particularly in healthcare, AI, and enterprise software. They provide access to advisors and clients in the Latin American market to drive business value for their portfolio companies.
What's next for Evidium?
The recent major strategic investment signifies a critical growth phase for Evidium, likely indicating a Series A or later stage of development focused on scaling operations and expanding market reach. This substantial capital infusion is expected to fuel further technological advancements, bolster sales and marketing efforts, and potentially explore new strategic partnerships within the healthcare ecosystem. Evidium's focus on explainable AI in healthcare positions it to capitalize on the increasing demand for data-driven decision-making and improved patient outcomes, suggesting a trajectory towards significant market penetration and industry influence.
See full Evidium company page
